MTSS1 and hepatocellular carcinoma: Many studies have found that loss of MTSS1 is detrimental to patient survival and prognosis [32, 33, 47–50]; however, in both colorectal and hepatocellular carcinoma, data show that elevated MTSS1 is an indicator of poor prognosis [51, 52].